Luca Pangrazzi MSc (University of Milano-Bicocca)
Postdoctoral fellow, University of Innsbruck, Innsbruck · Austria
Editorial leadership for Journal of Aging Research And Healthcare ISSN 2474-7785
Research interests
- Immunology
- Neuroscience
- Inflammation
- Immune System
- Autism
- Aging
Biography
Luca Pangrazzi, MSc, is a Postdoctoral Fellow at the University of Innsbruck, Innsbruck, Austria. He completed his graduate education at the University of Milano-Bicocca and has established a research program spanning immunology, neuroscience, inflammation, and the immune system, with particular focus on autism. His work on T cell phenotyping has made significant contributions to the field, exemplified by his most-cited publication, "CD28 and CD57 define four populations with distinct phenotypic properties within human CD8 + T cells" (2019), which has been cited 58 times and advanced understanding of immune cell heterogeneity.
Selected publications
- CD28 and CD57 define four populations with distinct phenotypic properties within human CD8 + T cells 2019 cited 58×
- Natural Antioxidants: A Novel Therapeutic Approach to Autism Spectrum Disorders? 2020 cited 57×
- Molecular and Cellular Mechanisms of Immunosenescence: Modulation Through Interventions and Lifestyle Changes 2024 cited 24×
- The impact of oxidative stress, inflammation, and senescence on the maintenance of immunological memory in the bone marrow in old age 2019 cited 21×
- Antioxidants N-Acetylcysteine and Vitamin C Improve T Cell Commitment to Memory and Long-Term Maintenance of Immunological Memory in Old Mice 2020 cited 16×
- N-Acetylcysteine Counteracts Immune Dysfunction and Autism-Related Behaviors in the Shank3b Mouse Model of Autism Spectrum Disorder 2024 cited 8×
Ranked by citation impact (Crossref) where available, newest otherwise · verified via ORCID.
Considering JARH for your work?
This journal is guided by Luca Pangrazzi (Postdoctoral fellow, University of Innsbruck, Innsbruck) and a peer-review board of practising researchers. Open access, author-retained copyright (CC BY), and a clear editorial process.